Epidemiological Trends, Etiology, and Burden Study of Heart Failure in China, 1990–2019

IF 1.6 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of interventional cardiology Pub Date : 2024-11-19 DOI:10.1155/2024/5139756
Tao Ying, Han Wang, Qiong Nie, Wei Yan, Jing Wu
{"title":"Epidemiological Trends, Etiology, and Burden Study of Heart Failure in China, 1990–2019","authors":"Tao Ying,&nbsp;Han Wang,&nbsp;Qiong Nie,&nbsp;Wei Yan,&nbsp;Jing Wu","doi":"10.1155/2024/5139756","DOIUrl":null,"url":null,"abstract":"<div>\n <p><b>Background:</b> Despite the enormous impact of heart failure (HF) in China, there is a relative lack of research on its epidemiologic trends and burden. Therefore, there is an urgent need for a comprehensive and in-depth analysis of the epidemiologic patterns, underlying etiology, and overall burden of HF.</p>\n <p><b>Objective:</b> This study aimed to elucidate the epidemiology, etiology, and burden of HF in China and provided a comprehensive and up-to-date analysis, including temporal trends from 1900 to 2019.</p>\n <p><b>Methods:</b> The data for this study were derived from the Global Burden of Disease (GBD) study 2019. Descriptive analyses were conducted to examine the prevalence and years lived with disability (YLD) rates in China from 1990 to 2019, with variables including year, sex, and age. To illustrate the temporal trend spanning 1990 to 2019, estimated average annual percentage changes (AAPC) were calculated.</p>\n <p><b>Results:</b> In 2019, the number of prevalent HF cases in China was 18.51 million (95% uncertainty interval [UI]: 14.97 to 23.02 million), representing 32.9% of the global prevalence. Between 1990 and 2019, the number of cases and the prevalence rates of HF in China showed an increasing trend. The age-standardized prevalence rates (ASPRs) demonstrated an overall declining trend (AAPC = −0.16, 95% confidence interval [CI]: −0.19 to −0.13, <i>p</i> &lt; 0.01), as did the age-standardized YLD rates (AAPC = −0.13, 95% CI: −0.16 to −0.1, <i>p</i> &lt; 0.01). However, from 2017 to 2019, a gradual increase was observed (AAPC = 1.72, 95% CI: 1.47 to 1.96, <i>p</i> &lt; 0.01). In the age-based analysis, individuals aged 55 years and older accounted for 88.3% of the prevalent cases. Women exhibited higher case numbers and ASPR compared to men. In the cause-based analysis, hypertensive heart disease emerged as the primary etiology of HF in China.</p>\n <p><b>Conclusion:</b> From 1990 to 2019, the ASPR and age-standardized YLD rates for HF in China demonstrated an overall decreasing trend. Nevertheless, the trend increased from 2017 to 2019, with significant variations observed by gender and age. Therefore, continued attention to the disease burden of HF in China remains essential. Healthy lifestyles are important for minimizing the prevalence of HF. In addition, it is necessary to address and reduce the incidence of hypertension from all causes to mitigate the disease burden further.</p>\n </div>","PeriodicalId":16329,"journal":{"name":"Journal of interventional cardiology","volume":"2024 1","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/5139756","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of interventional cardiology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/2024/5139756","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Despite the enormous impact of heart failure (HF) in China, there is a relative lack of research on its epidemiologic trends and burden. Therefore, there is an urgent need for a comprehensive and in-depth analysis of the epidemiologic patterns, underlying etiology, and overall burden of HF.

Objective: This study aimed to elucidate the epidemiology, etiology, and burden of HF in China and provided a comprehensive and up-to-date analysis, including temporal trends from 1900 to 2019.

Methods: The data for this study were derived from the Global Burden of Disease (GBD) study 2019. Descriptive analyses were conducted to examine the prevalence and years lived with disability (YLD) rates in China from 1990 to 2019, with variables including year, sex, and age. To illustrate the temporal trend spanning 1990 to 2019, estimated average annual percentage changes (AAPC) were calculated.

Results: In 2019, the number of prevalent HF cases in China was 18.51 million (95% uncertainty interval [UI]: 14.97 to 23.02 million), representing 32.9% of the global prevalence. Between 1990 and 2019, the number of cases and the prevalence rates of HF in China showed an increasing trend. The age-standardized prevalence rates (ASPRs) demonstrated an overall declining trend (AAPC = −0.16, 95% confidence interval [CI]: −0.19 to −0.13, p < 0.01), as did the age-standardized YLD rates (AAPC = −0.13, 95% CI: −0.16 to −0.1, p < 0.01). However, from 2017 to 2019, a gradual increase was observed (AAPC = 1.72, 95% CI: 1.47 to 1.96, p < 0.01). In the age-based analysis, individuals aged 55 years and older accounted for 88.3% of the prevalent cases. Women exhibited higher case numbers and ASPR compared to men. In the cause-based analysis, hypertensive heart disease emerged as the primary etiology of HF in China.

Conclusion: From 1990 to 2019, the ASPR and age-standardized YLD rates for HF in China demonstrated an overall decreasing trend. Nevertheless, the trend increased from 2017 to 2019, with significant variations observed by gender and age. Therefore, continued attention to the disease burden of HF in China remains essential. Healthy lifestyles are important for minimizing the prevalence of HF. In addition, it is necessary to address and reduce the incidence of hypertension from all causes to mitigate the disease burden further.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
1990-2019 年中国心力衰竭的流行趋势、病因和负担研究
背景:尽管心力衰竭(HF)在中国影响巨大,但对其流行病学趋势和负担的研究却相对缺乏。因此,迫切需要对心力衰竭的流行病学模式、潜在病因和总体负担进行全面深入的分析。 研究目的本研究旨在阐明中国高血压的流行病学、病因学和负担,并提供全面的最新分析,包括从 1900 年到 2019 年的时间趋势。 研究方法本研究的数据来自 2019 年全球疾病负担(GBD)研究。通过描述性分析,研究了1990年至2019年中国的患病率和残疾生存年数(YLD),变量包括年份、性别和年龄。为了说明 1990 年至 2019 年的时间趋势,计算了估计的年均百分比变化(AAPC)。 结果:2019年,中国的高频患病人数为1851万(95%不确定区间[UI]:1497万至2302万),占全球患病人数的32.9%。从 1990 年到 2019 年,中国的心房颤动病例数和患病率均呈上升趋势。年龄标准化患病率(ASPRs)总体呈下降趋势(AAPC = -0.16,95%置信区间[CI]:-0.19至-0.13,p < 0.01),年龄标准化YLD率也是如此(AAPC = -0.13,95% CI:-0.16至-0.1,p < 0.01)。然而,从 2017 年到 2019 年,观察到了逐渐上升的趋势(AAPC = 1.72,95% CI:1.47 至 1.96,p <0.01)。在基于年龄的分析中,55 岁及以上人群占流行病例的 88.3%。与男性相比,女性的病例数和 ASPR 均较高。在基于病因的分析中,高血压性心脏病成为中国心房颤动的主要病因。 结论从 1990 年到 2019 年,中国心房颤动的 ASPR 和年龄标准化 YLD 率总体呈下降趋势。然而,从 2017 年到 2019 年,这一趋势有所上升,并观察到不同性别和年龄的显著差异。因此,继续关注中国的心房颤动疾病负担仍然至关重要。健康的生活方式对于最大限度地降低心房颤动的患病率非常重要。此外,有必要解决并降低各种原因引起的高血压发病率,以进一步减轻疾病负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of interventional cardiology
Journal of interventional cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.80
自引率
0.00%
发文量
81
审稿时长
6-12 weeks
期刊介绍: Journal of Interventional Cardiology is a peer-reviewed, Open Access journal that provides a forum for cardiologists determined to stay current in the diagnosis, investigation, and management of patients with cardiovascular disease and its associated complications. The journal publishes original research articles, review articles, and clinical studies focusing on new procedures and techniques in all major subject areas in the field, including: Acute coronary syndrome Coronary disease Congenital heart diseases Myocardial infarction Peripheral arterial disease Valvular heart disease Cardiac hemodynamics and physiology Haemostasis and thrombosis
期刊最新文献
Epidemiological Trends, Etiology, and Burden Study of Heart Failure in China, 1990–2019 A Comparative Analysis of Primary and Bailout ADR in CTO-PCI The Effect of Electromagnetic Interference Produced by Smartphones Using 5G Network on Patients With Permanent Pacemakers (EMS5G-PPM Study) Comparison of Sheathless and Sheathed Guiding Catheters in Transradial Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis Percutaneous Coronary Intervention Using the DynamX Sirolimus-Eluting Bioadaptor: 12-Month Clinical and Imaging Outcomes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1